aluates Reports

$ 0.0

Automative

Global Psoriatic Arthritis (PsA) Treatment Market Research Report 2025

Published Date: September 2025

Report Code: QYRE-Auto-6K1293

Global Psoriatic Arthritis PsA Treatment Market Insights and Forecast to 2028

BUY CHAPTERS

Global Psoriatic Arthritis (PsA) Treatment Market Research Report 2025

Code: QYRE-Auto-6K1293

Report

September 2025

Pages:87

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Pfizer Inc

Johnson & Johnson

AbbVie

Novartis

UCB

Roche

Bristol–Myers Squibb

Eli Lilly

Amgen Inc

Astrazeneca plc

Celgene

Johnson & Johnson

Psoriatic Arthritis (PsA) Treatment Market Size

The global market for Psoriatic Arthritis (PsA) Treatment was valued at US$ 11010 million in the year 2024 and is projected to reach a revised size of US$ 18720 million by 2031, growing at a CAGR of 8.0% during the forecast period.

Psoriatic Arthritis (PsA) Treatment Market

Psoriatic arthritis (PsA) is a chronic, inflammatory disease of the joints and entheses, where tendons and ligaments connect to bone. Like psoriasis, PsA is associated with related health conditions (comorbidities).

It can start at any age and may affect children. The disease often appears between ages 30 and 50. For many people, it starts about 10 years after psoriasis develops, but some develop PsA first or without ever developing or noticing psoriasis.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Psoriatic Arthritis (PsA) Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Psoriatic Arthritis (PsA) Treatment.

The Psoriatic Arthritis (PsA) Treatment market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Psoriatic Arthritis (PsA) Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Psoriatic Arthritis (PsA) Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Psoriatic Arthritis (PsA) Treatment Market Report

Report Metric	Details
Report Name	Psoriatic Arthritis (PsA) Treatment Market
Accounted market size in year	US$ 11010 million
Forecasted market size in 2031	US$ 18720 million
CAGR	8.0%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Nonsteriodal Anti-inflammatory Drugs Disease Modifying Antirheumatic Drugs Biologics
Segment by Application	Hospitals Clinics Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Pfizer, Johnson & Johnson, AbbVie, Novartis, UCB, Roche, Bristol-Myers Squibb, Eli Lilly, Amgen, AstraZeneca, Celgene
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Psoriatic Arthritis (PsA) Treatment company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Psoriatic Arthritis (PsA) Treatment Market growing?

Ans: The Psoriatic Arthritis (PsA) Treatment Market witnessing a CAGR of 8.0% during the forecast period 2025-2031.

What is the Psoriatic Arthritis (PsA) Treatment Market size in 2031?

Ans: The Psoriatic Arthritis (PsA) Treatment Market size in 2031 will be US$ 18720 million.

Who are the main players in the Psoriatic Arthritis (PsA) Treatment Market report?

Ans: The main players in the Psoriatic Arthritis (PsA) Treatment Market are Pfizer, Johnson & Johnson, AbbVie, Novartis, UCB, Roche, Bristol-Myers Squibb, Eli Lilly, Amgen, AstraZeneca, Celgene

What are the Application segmentation covered in the Psoriatic Arthritis (PsA) Treatment Market report?

Ans: The Applications covered in the Psoriatic Arthritis (PsA) Treatment Market report are Hospitals, Clinics, Others

What are the Type segmentation covered in the Psoriatic Arthritis (PsA) Treatment Market report?

Ans: The Types covered in the Psoriatic Arthritis (PsA) Treatment Market report are Nonsteriodal Anti-inflammatory Drugs, Disease Modifying Antirheumatic Drugs, Biologics

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Psoriatic Arthritis (PsA) Treatment Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Nonsteriodal Anti-inflammatory Drugs

1.2.3 Disease Modifying Antirheumatic Drugs

1.2.4 Biologics

1.3 Market by Application

1.3.1 Global Psoriatic Arthritis (PsA) Treatment Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Hospitals

1.3.3 Clinics

1.3.4 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Psoriatic Arthritis (PsA) Treatment Market Perspective (2020-2031)

2.2 Global Psoriatic Arthritis (PsA) Treatment Growth Trends by Region

2.2.1 Global Psoriatic Arthritis (PsA) Treatment Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Psoriatic Arthritis (PsA) Treatment Historic Market Size by Region (2020-2025)

2.2.3 Psoriatic Arthritis (PsA) Treatment Forecasted Market Size by Region (2026-2031)

2.3 Psoriatic Arthritis (PsA) Treatment Market Dynamics

2.3.1 Psoriatic Arthritis (PsA) Treatment Industry Trends

2.3.2 Psoriatic Arthritis (PsA) Treatment Market Drivers

2.3.3 Psoriatic Arthritis (PsA) Treatment Market Challenges

2.3.4 Psoriatic Arthritis (PsA) Treatment Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Psoriatic Arthritis (PsA) Treatment Players by Revenue

3.1.1 Global Top Psoriatic Arthritis (PsA) Treatment Players by Revenue (2020-2025)

3.1.2 Global Psoriatic Arthritis (PsA) Treatment Revenue Market Share by Players (2020-2025)

3.2 Global Psoriatic Arthritis (PsA) Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Psoriatic Arthritis (PsA) Treatment Revenue

3.4 Global Psoriatic Arthritis (PsA) Treatment Market Concentration Ratio

3.4.1 Global Psoriatic Arthritis (PsA) Treatment Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Psoriatic Arthritis (PsA) Treatment Revenue in 2024

3.5 Global Key Players of Psoriatic Arthritis (PsA) Treatment Head office and Area Served

3.6 Global Key Players of Psoriatic Arthritis (PsA) Treatment, Product and Application

3.7 Global Key Players of Psoriatic Arthritis (PsA) Treatment, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Psoriatic Arthritis (PsA) Treatment Breakdown Data by Type

4.1 Global Psoriatic Arthritis (PsA) Treatment Historic Market Size by Type (2020-2025)

4.2 Global Psoriatic Arthritis (PsA) Treatment Forecasted Market Size by Type (2026-2031)

5 Psoriatic Arthritis (PsA) Treatment Breakdown Data by Application

5.1 Global Psoriatic Arthritis (PsA) Treatment Historic Market Size by Application (2020-2025)

5.2 Global Psoriatic Arthritis (PsA) Treatment Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Psoriatic Arthritis (PsA) Treatment Market Size (2020-2031)

6.2 North America Psoriatic Arthritis (PsA) Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Psoriatic Arthritis (PsA) Treatment Market Size by Country (2020-2025)

6.4 North America Psoriatic Arthritis (PsA) Treatment Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Psoriatic Arthritis (PsA) Treatment Market Size (2020-2031)

7.2 Europe Psoriatic Arthritis (PsA) Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Psoriatic Arthritis (PsA) Treatment Market Size by Country (2020-2025)

7.4 Europe Psoriatic Arthritis (PsA) Treatment Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Psoriatic Arthritis (PsA) Treatment Market Size (2020-2031)

8.2 Asia-Pacific Psoriatic Arthritis (PsA) Treatment Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Psoriatic Arthritis (PsA) Treatment Market Size by Region (2020-2025)

8.4 Asia-Pacific Psoriatic Arthritis (PsA) Treatment Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Psoriatic Arthritis (PsA) Treatment Market Size (2020-2031)

9.2 Latin America Psoriatic Arthritis (PsA) Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Psoriatic Arthritis (PsA) Treatment Market Size by Country (2020-2025)

9.4 Latin America Psoriatic Arthritis (PsA) Treatment Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Psoriatic Arthritis (PsA) Treatment Market Size (2020-2031)

10.2 Middle East & Africa Psoriatic Arthritis (PsA) Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Psoriatic Arthritis (PsA) Treatment Market Size by Country (2020-2025)

10.4 Middle East & Africa Psoriatic Arthritis (PsA) Treatment Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Pfizer

11.1.1 Pfizer Company Details

11.1.2 Pfizer Business Overview

11.1.3 Pfizer Psoriatic Arthritis (PsA) Treatment Introduction

11.1.4 Pfizer Revenue in Psoriatic Arthritis (PsA) Treatment Business (2020-2025)

11.1.5 Pfizer Recent Development

11.2 Johnson & Johnson

11.2.1 Johnson & Johnson Company Details

11.2.2 Johnson & Johnson Business Overview

11.2.3 Johnson & Johnson Psoriatic Arthritis (PsA) Treatment Introduction

11.2.4 Johnson & Johnson Revenue in Psoriatic Arthritis (PsA) Treatment Business (2020-2025)

11.2.5 Johnson & Johnson Recent Development

11.3 AbbVie

11.3.1 AbbVie Company Details

11.3.2 AbbVie Business Overview

11.3.3 AbbVie Psoriatic Arthritis (PsA) Treatment Introduction

11.3.4 AbbVie Revenue in Psoriatic Arthritis (PsA) Treatment Business (2020-2025)

11.3.5 AbbVie Recent Development

11.4 Novartis

11.4.1 Novartis Company Details

11.4.2 Novartis Business Overview

11.4.3 Novartis Psoriatic Arthritis (PsA) Treatment Introduction

11.4.4 Novartis Revenue in Psoriatic Arthritis (PsA) Treatment Business (2020-2025)

11.4.5 Novartis Recent Development

11.5 UCB

11.5.1 UCB Company Details

11.5.2 UCB Business Overview

11.5.3 UCB Psoriatic Arthritis (PsA) Treatment Introduction

11.5.4 UCB Revenue in Psoriatic Arthritis (PsA) Treatment Business (2020-2025)

11.5.5 UCB Recent Development

11.6 Roche

11.6.1 Roche Company Details

11.6.2 Roche Business Overview

11.6.3 Roche Psoriatic Arthritis (PsA) Treatment Introduction

11.6.4 Roche Revenue in Psoriatic Arthritis (PsA) Treatment Business (2020-2025)

11.6.5 Roche Recent Development

11.7 Bristol-Myers Squibb

11.7.1 Bristol-Myers Squibb Company Details

11.7.2 Bristol-Myers Squibb Business Overview

11.7.3 Bristol-Myers Squibb Psoriatic Arthritis (PsA) Treatment Introduction

11.7.4 Bristol-Myers Squibb Revenue in Psoriatic Arthritis (PsA) Treatment Business (2020-2025)

11.7.5 Bristol-Myers Squibb Recent Development

11.8 Eli Lilly

11.8.1 Eli Lilly Company Details

11.8.2 Eli Lilly Business Overview

11.8.3 Eli Lilly Psoriatic Arthritis (PsA) Treatment Introduction

11.8.4 Eli Lilly Revenue in Psoriatic Arthritis (PsA) Treatment Business (2020-2025)

11.8.5 Eli Lilly Recent Development

11.9 Amgen

11.9.1 Amgen Company Details

11.9.2 Amgen Business Overview

11.9.3 Amgen Psoriatic Arthritis (PsA) Treatment Introduction

11.9.4 Amgen Revenue in Psoriatic Arthritis (PsA) Treatment Business (2020-2025)

11.9.5 Amgen Recent Development

11.10 AstraZeneca

11.10.1 AstraZeneca Company Details

11.10.2 AstraZeneca Business Overview

11.10.3 AstraZeneca Psoriatic Arthritis (PsA) Treatment Introduction

11.10.4 AstraZeneca Revenue in Psoriatic Arthritis (PsA) Treatment Business (2020-2025)

11.10.5 AstraZeneca Recent Development

11.11 Celgene

11.11.1 Celgene Company Details

11.11.2 Celgene Business Overview

11.11.3 Celgene Psoriatic Arthritis (PsA) Treatment Introduction

11.11.4 Celgene Revenue in Psoriatic Arthritis (PsA) Treatment Business (2020-2025)

11.11.5 Celgene Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Pfizer Inc

Johnson & Johnson

AbbVie

Novartis

UCB

Roche

Bristol–Myers Squibb

Eli Lilly

Amgen Inc

Astrazeneca plc

Celgene

Johnson & Johnson

List of Tables

Table 1. Global Psoriatic Arthritis (PsA) Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Nonsteriodal Anti-inflammatory Drugs

Table 3. Key Players of Disease Modifying Antirheumatic Drugs

Table 4. Key Players of Biologics

Table 5. Global Psoriatic Arthritis (PsA) Treatment Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Psoriatic Arthritis (PsA) Treatment Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 7. Global Psoriatic Arthritis (PsA) Treatment Market Size by Region (2020-2025) & (US$ Million)

Table 8. Global Psoriatic Arthritis (PsA) Treatment Market Share by Region (2020-2025)

Table 9. Global Psoriatic Arthritis (PsA) Treatment Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 10. Global Psoriatic Arthritis (PsA) Treatment Market Share by Region (2026-2031)

Table 11. Psoriatic Arthritis (PsA) Treatment Market Trends

Table 12. Psoriatic Arthritis (PsA) Treatment Market Drivers

Table 13. Psoriatic Arthritis (PsA) Treatment Market Challenges

Table 14. Psoriatic Arthritis (PsA) Treatment Market Restraints

Table 15. Global Psoriatic Arthritis (PsA) Treatment Revenue by Players (2020-2025) & (US$ Million)

Table 16. Global Psoriatic Arthritis (PsA) Treatment Market Share by Players (2020-2025)

Table 17. Global Top Psoriatic Arthritis (PsA) Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Psoriatic Arthritis (PsA) Treatment as of 2024)

Table 18. Ranking of Global Top Psoriatic Arthritis (PsA) Treatment Companies by Revenue (US$ Million) in 2024

Table 19. Global 5 Largest Players Market Share by Psoriatic Arthritis (PsA) Treatment Revenue (CR5 and HHI) & (2020-2025)

Table 20. Global Key Players of Psoriatic Arthritis (PsA) Treatment, Headquarters and Area Served

Table 21. Global Key Players of Psoriatic Arthritis (PsA) Treatment, Product and Application

Table 22. Global Key Players of Psoriatic Arthritis (PsA) Treatment, Date of Enter into This Industry

Table 23. Mergers & Acquisitions, Expansion Plans

Table 24. Global Psoriatic Arthritis (PsA) Treatment Market Size by Type (2020-2025) & (US$ Million)

Table 25. Global Psoriatic Arthritis (PsA) Treatment Revenue Market Share by Type (2020-2025)

Table 26. Global Psoriatic Arthritis (PsA) Treatment Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 27. Global Psoriatic Arthritis (PsA) Treatment Revenue Market Share by Type (2026-2031)

Table 28. Global Psoriatic Arthritis (PsA) Treatment Market Size by Application (2020-2025) & (US$ Million)

Table 29. Global Psoriatic Arthritis (PsA) Treatment Revenue Market Share by Application (2020-2025)

Table 30. Global Psoriatic Arthritis (PsA) Treatment Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 31. Global Psoriatic Arthritis (PsA) Treatment Revenue Market Share by Application (2026-2031)

Table 32. North America Psoriatic Arthritis (PsA) Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 33. North America Psoriatic Arthritis (PsA) Treatment Market Size by Country (2020-2025) & (US$ Million)

Table 34. North America Psoriatic Arthritis (PsA) Treatment Market Size by Country (2026-2031) & (US$ Million)

Table 35. Europe Psoriatic Arthritis (PsA) Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 36. Europe Psoriatic Arthritis (PsA) Treatment Market Size by Country (2020-2025) & (US$ Million)

Table 37. Europe Psoriatic Arthritis (PsA) Treatment Market Size by Country (2026-2031) & (US$ Million)

Table 38. Asia-Pacific Psoriatic Arthritis (PsA) Treatment Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 39. Asia-Pacific Psoriatic Arthritis (PsA) Treatment Market Size by Region (2020-2025) & (US$ Million)

Table 40. Asia-Pacific Psoriatic Arthritis (PsA) Treatment Market Size by Region (2026-2031) & (US$ Million)

Table 41. Latin America Psoriatic Arthritis (PsA) Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 42. Latin America Psoriatic Arthritis (PsA) Treatment Market Size by Country (2020-2025) & (US$ Million)

Table 43. Latin America Psoriatic Arthritis (PsA) Treatment Market Size by Country (2026-2031) & (US$ Million)

Table 44. Middle East & Africa Psoriatic Arthritis (PsA) Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 45. Middle East & Africa Psoriatic Arthritis (PsA) Treatment Market Size by Country (2020-2025) & (US$ Million)

Table 46. Middle East & Africa Psoriatic Arthritis (PsA) Treatment Market Size by Country (2026-2031) & (US$ Million)

Table 47. Pfizer Company Details

Table 48. Pfizer Business Overview

Table 49. Pfizer Psoriatic Arthritis (PsA) Treatment Product

Table 50. Pfizer Revenue in Psoriatic Arthritis (PsA) Treatment Business (2020-2025) & (US$ Million)

Table 51. Pfizer Recent Development

Table 52. Johnson & Johnson Company Details

Table 53. Johnson & Johnson Business Overview

Table 54. Johnson & Johnson Psoriatic Arthritis (PsA) Treatment Product

Table 55. Johnson & Johnson Revenue in Psoriatic Arthritis (PsA) Treatment Business (2020-2025) & (US$ Million)

Table 56. Johnson & Johnson Recent Development

Table 57. AbbVie Company Details

Table 58. AbbVie Business Overview

Table 59. AbbVie Psoriatic Arthritis (PsA) Treatment Product

Table 60. AbbVie Revenue in Psoriatic Arthritis (PsA) Treatment Business (2020-2025) & (US$ Million)

Table 61. AbbVie Recent Development

Table 62. Novartis Company Details

Table 63. Novartis Business Overview

Table 64. Novartis Psoriatic Arthritis (PsA) Treatment Product

Table 65. Novartis Revenue in Psoriatic Arthritis (PsA) Treatment Business (2020-2025) & (US$ Million)

Table 66. Novartis Recent Development

Table 67. UCB Company Details

Table 68. UCB Business Overview

Table 69. UCB Psoriatic Arthritis (PsA) Treatment Product

Table 70. UCB Revenue in Psoriatic Arthritis (PsA) Treatment Business (2020-2025) & (US$ Million)

Table 71. UCB Recent Development

Table 72. Roche Company Details

Table 73. Roche Business Overview

Table 74. Roche Psoriatic Arthritis (PsA) Treatment Product

Table 75. Roche Revenue in Psoriatic Arthritis (PsA) Treatment Business (2020-2025) & (US$ Million)

Table 76. Roche Recent Development

Table 77. Bristol-Myers Squibb Company Details

Table 78. Bristol-Myers Squibb Business Overview

Table 79. Bristol-Myers Squibb Psoriatic Arthritis (PsA) Treatment Product

Table 80. Bristol-Myers Squibb Revenue in Psoriatic Arthritis (PsA) Treatment Business (2020-2025) & (US$ Million)

Table 81. Bristol-Myers Squibb Recent Development

Table 82. Eli Lilly Company Details

Table 83. Eli Lilly Business Overview

Table 84. Eli Lilly Psoriatic Arthritis (PsA) Treatment Product

Table 85. Eli Lilly Revenue in Psoriatic Arthritis (PsA) Treatment Business (2020-2025) & (US$ Million)

Table 86. Eli Lilly Recent Development

Table 87. Amgen Company Details

Table 88. Amgen Business Overview

Table 89. Amgen Psoriatic Arthritis (PsA) Treatment Product

Table 90. Amgen Revenue in Psoriatic Arthritis (PsA) Treatment Business (2020-2025) & (US$ Million)

Table 91. Amgen Recent Development

Table 92. AstraZeneca Company Details

Table 93. AstraZeneca Business Overview

Table 94. AstraZeneca Psoriatic Arthritis (PsA) Treatment Product

Table 95. AstraZeneca Revenue in Psoriatic Arthritis (PsA) Treatment Business (2020-2025) & (US$ Million)

Table 96. AstraZeneca Recent Development

Table 97. Celgene Company Details

Table 98. Celgene Business Overview

Table 99. Celgene Psoriatic Arthritis (PsA) Treatment Product

Table 100. Celgene Revenue in Psoriatic Arthritis (PsA) Treatment Business (2020-2025) & (US$ Million)

Table 101. Celgene Recent Development

Table 102. Research Programs/Design for This Report

Table 103. Key Data Information from Secondary Sources

Table 104. Key Data Information from Primary Sources

Table 105. Authors List of This Report

List of Figures

Figure 1. Psoriatic Arthritis (PsA) Treatment Picture

Figure 2. Global Psoriatic Arthritis (PsA) Treatment Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Psoriatic Arthritis (PsA) Treatment Market Share by Type: 2024 VS 2031

Figure 4. Nonsteriodal Anti-inflammatory Drugs Features

Figure 5. Disease Modifying Antirheumatic Drugs Features

Figure 6. Biologics Features

Figure 7. Global Psoriatic Arthritis (PsA) Treatment Market Size by Application (2020-2031) & (US$ Million)

Figure 8. Global Psoriatic Arthritis (PsA) Treatment Market Share by Application: 2024 VS 2031

Figure 9. Hospitals Case Studies

Figure 10. Clinics Case Studies

Figure 11. Others Case Studies

Figure 12. Psoriatic Arthritis (PsA) Treatment Report Years Considered

Figure 13. Global Psoriatic Arthritis (PsA) Treatment Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 14. Global Psoriatic Arthritis (PsA) Treatment Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 15. Global Psoriatic Arthritis (PsA) Treatment Market Share by Region: 2024 VS 2031

Figure 16. Global Psoriatic Arthritis (PsA) Treatment Market Share by Players in 2024

Figure 17. Global Top Psoriatic Arthritis (PsA) Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Psoriatic Arthritis (PsA) Treatment as of 2024)

Figure 18. The Top 10 and 5 Players Market Share by Psoriatic Arthritis (PsA) Treatment Revenue in 2024

Figure 19. North America Psoriatic Arthritis (PsA) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 20. North America Psoriatic Arthritis (PsA) Treatment Market Share by Country (2020-2031)

Figure 21. United States Psoriatic Arthritis (PsA) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. Canada Psoriatic Arthritis (PsA) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Europe Psoriatic Arthritis (PsA) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Europe Psoriatic Arthritis (PsA) Treatment Market Share by Country (2020-2031)

Figure 25. Germany Psoriatic Arthritis (PsA) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. France Psoriatic Arthritis (PsA) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. U.K. Psoriatic Arthritis (PsA) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Italy Psoriatic Arthritis (PsA) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Russia Psoriatic Arthritis (PsA) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Nordic Countries Psoriatic Arthritis (PsA) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Asia-Pacific Psoriatic Arthritis (PsA) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Asia-Pacific Psoriatic Arthritis (PsA) Treatment Market Share by Region (2020-2031)

Figure 33. China Psoriatic Arthritis (PsA) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Japan Psoriatic Arthritis (PsA) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. South Korea Psoriatic Arthritis (PsA) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Southeast Asia Psoriatic Arthritis (PsA) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. India Psoriatic Arthritis (PsA) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Australia Psoriatic Arthritis (PsA) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Latin America Psoriatic Arthritis (PsA) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Latin America Psoriatic Arthritis (PsA) Treatment Market Share by Country (2020-2031)

Figure 41. Mexico Psoriatic Arthritis (PsA) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Brazil Psoriatic Arthritis (PsA) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Middle East & Africa Psoriatic Arthritis (PsA) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Middle East & Africa Psoriatic Arthritis (PsA) Treatment Market Share by Country (2020-2031)

Figure 45. Turkey Psoriatic Arthritis (PsA) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Saudi Arabia Psoriatic Arthritis (PsA) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. UAE Psoriatic Arthritis (PsA) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. Pfizer Revenue Growth Rate in Psoriatic Arthritis (PsA) Treatment Business (2020-2025)

Figure 49. Johnson & Johnson Revenue Growth Rate in Psoriatic Arthritis (PsA) Treatment Business (2020-2025)

Figure 50. AbbVie Revenue Growth Rate in Psoriatic Arthritis (PsA) Treatment Business (2020-2025)

Figure 51. Novartis Revenue Growth Rate in Psoriatic Arthritis (PsA) Treatment Business (2020-2025)

Figure 52. UCB Revenue Growth Rate in Psoriatic Arthritis (PsA) Treatment Business (2020-2025)

Figure 53. Roche Revenue Growth Rate in Psoriatic Arthritis (PsA) Treatment Business (2020-2025)

Figure 54. Bristol-Myers Squibb Revenue Growth Rate in Psoriatic Arthritis (PsA) Treatment Business (2020-2025)

Figure 55. Eli Lilly Revenue Growth Rate in Psoriatic Arthritis (PsA) Treatment Business (2020-2025)

Figure 56. Amgen Revenue Growth Rate in Psoriatic Arthritis (PsA) Treatment Business (2020-2025)

Figure 57. AstraZeneca Revenue Growth Rate in Psoriatic Arthritis (PsA) Treatment Business (2020-2025)

Figure 58. Celgene Revenue Growth Rate in Psoriatic Arthritis (PsA) Treatment Business (2020-2025)

Figure 59. Bottom-up and Top-down Approaches for This Report

Figure 60. Data Triangulation

Figure 61. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Psoriasis Therapeutics Market Insights Forecast to 2030

Global Psoriatic Arthritis Treatment Drugs Market Research Report 2025

Global Juvenile Idiopathic Arthritis Diagnostic Market Research Report 2024

Global Biopharmaceuticals for Psoriasis Market Research Report 2024

Psoriatic Arthritis Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Pediatric Psoriasis Market Research Report 2024

Global Plaque Psoriasis Treatment Medications Market Research Report 2024

Global Juvenile Idiopathic Arthritis Treatment Market Insights Forecast to 2030

Global Psoriasis Biosimilar Market Research Report 2024

Global Chronic Plaque Psoriasis Therapeutics Market Research Report 2024

Global Juvenile Idiopathic Arthritis Therapeutics Market Research Report 2025

Global Rheumatoid Arthritis Medicine Market Research Report 2025

Psoriasis Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Psoriasis Treatment Drugs Market Research Report 2025

Global Mild to Moderate Atopic Dermatitis Treatment Market Research Report 2024

Global Benign Prostatic Hyperplasia BPH Drugs Market Insights Forecast to 2030

Global Biologic Medications for Psoriasis Market Research Report 2024

Global Psoriasis Biologics Drugs Market Research Report 2025

Global Moderate to Severe Plaque Psoriasis Medications Market Research Report 2024

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions